We previously demonstrated the efficacy of resveratrol (RVL) in restoring the function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). This study examined the ...

The interferon gamma signaling pathway may be a common feature in the pathophysiology of various forms of ANCA-associated vasculitis. This study received financial support from multiple ...

Provision of written informed consent by patients themselves or their legally acceptable representative. Age ≥20 years at the time of consent. New diagnosis of ANCA-associated vasculitis (MPA, GPA or ...

The frequency of damage may therefore be under-represented. Additionally, the VDI may not adequately capture the range of damage seen in ANCA-associated vasculitis,14 and may underestimate damage ...

Objective Treatment-refractory antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a life-threatening condition without evidence-based treatment options. One emerging treatment ...

have been included because only studies on the intestinal microbiome in immunoglobulin A vasculitis, antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, Kawasaki disease, Behcet’s ...

Rituximab versus cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial (RAVE). Arthritis Rheum. [ online ], (2009).

The European League Against Rheumatism (EULAR) recommendations for the management of small-vessel and medium-vessel vasculitides were recently updated, with a focus on antineutrophilic cytoplasmic ...

This content was created by our physicians and experts. A 65-year-old man with a history of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), congestive heart failure, and ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...